Oxolife SL Company

Oxolife is a small-sized clinical-stage biotech company focused and committed to female fertility improvement. The company is developing a first-in-class drug acting directly on the endometrium enhancing embryo implantation and increasing Life Birth Rates.

Investors

Industry: Reproductive Health & Contraception
Headquarters: Barcelona, Spain
Founded Date: 18-01-2013
Employees Number: 1-10
Investors Number: 1
Total Funding: $10,000,000
Estimated Revenue: Pre-revenue
Last Funding Date: 2021-01-28
Last Funding Type: Venture - Series Unknown

Visit Website
info@oxolife.com
https://twitter.com/oxolife
Register and Claim Ownership